State agencies in New Mexico have substantially improved their distribution of opioid settlement money following a rocky start that left millions of dollars unspent during the 2024 fiscal year, according to a report released by the New Mexico State Auditor’s Office.
The comprehensive review, published on September 15, 2026, evaluated how seven state-level entities managed approximately $54 million in settlement revenues across three consecutive fiscal years. The findings reveal a significant evolution in administrative capacity, moving from early implementation bottlenecks to near-total fund utilization.
During fiscal year 2024, which spanned from July 1, 2023, to June 30, 2024, state departments struggled to meet their spending targets. Participating public entities ended up returning more than $5 million of the $21 million distributed to them, meaning nearly 24% of the allocated resources went unused within the mandated operational timeframes.
The pace of deployment shifted dramatically over the subsequent two budget cycles. Across fiscal years 2025 and 2026, state agencies and public institutions such as the University of New Mexico successfully expended almost the entirety of their allocations, leaving only about 1% of the roughly $32 million in distributed funds unspent.
State Auditor Joseph Maestas welcomed the data, noting that the marked recovery illustrates growing institutional efficiency. In a public statement accompanying the report, Maestas described the post-2024 performance as an encouraging sign that state departments are actively learning, adjusting, and refining their procedures to deploy critical relief funds effectively.
The funds in question represent a portion of more than $920 million that New Mexico is slated to receive from sweeping national legal settlements. Out of this total compensation package, more than $328 million is designated specifically for state agencies, while more than $344 million is allocated to municipal and county governments across the state.
These multi-million-dollar disbursements began flowing in 2023 as the result of nationwide litigation against prescription opioid manufacturers, pharmaceutical distributors, and commercial pharmacy chains. The legal actions sought restitution for the industry’s role in initiating and inflaming an addiction crisis that has caused widespread community harm.
The impact of that crisis continues to be heavily felt across New Mexico, where the rate of fatal drug overdoses has consistently ranked among the highest in the country for the majority of the past two decades. As a consequence, state leaders have faced immense pressure to channel financial remedies directly into life-saving programs and support systems.
According to the auditor’s findings, several departments used their allocations to establish diverse public health interventions. The Health Care Authority directed settlement revenues toward supportive housing assistance, expanded telehealth capabilities, and the development of community behavioral health clinics aimed at long-term recovery.
Simultaneously, the New Mexico Department of Health and the Corrections Department channeled resources into direct mitigation measures. These initiatives included distributing overdose reversal medications to underserved rural communities and providing medication-assisted addiction treatment inside state correctional facilities.
Despite these programmatic expansions, certain departments experienced severe setbacks during the initial spending cycle. The New Mexico Children, Youth and Families Department failed to spend any portion of the $2 million it was allocated in fiscal year 2024, funds specifically earmarked to monitor and assist families caring for infants born with prenatal opioid exposure.
The child welfare agency did not provide an explanation to the auditor’s office regarding why the entire $2 million allocation remained untouched, and departmental representatives did not respond to inquiries regarding the unspent funds.
The audit noted that first-year spending lags across various public bodies were largely tied to operational hurdles. Many participating entities were launching entirely new programs that required hiring specialized staff, executing legal contracts, building regional service capacity, and forging inter-agency partnerships from scratch.
The new report marks the second recent evaluation published by the State Auditor’s Office concerning the handling of opioid litigation money. An earlier audit, which scrutinized local municipalities and county administrations, revealed that almost half of local government recipients had failed to report any expenditure of their settlement funds by July of the previous year.
State officials view the recent acceleration in state agency spending as a critical milestone. As New Mexico continues to absorb its remaining share of the $920 million settlement windfall, oversight authorities emphasize that maintaining rapid, transparent resource deployment remains vital to addressing the state’s protracted overdose epidemic.
(0)